MetaCap

NervGen Pharma SEC Filings

NASDAQ: NGENHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.73-0.02 (-1.14%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

NervGen Pharma filing overview

This page lists 15 recent SEC filings by NervGen Pharma (NGEN), including 14 6-K, 1 40-F. Form 10-K is the audited annual report, 10-Q the quarterly report, 8-K covers material events, and Form 4 reports insider transactions. All documents link directly to SEC EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

NGEN SEC filings

NervGen Pharma SEC filings
FiledFormDescriptionDocument
Sep 25, 20266-KReport of foreign private issuerView on EDGAR
Sep 24, 20266-KReport of foreign private issuerView on EDGAR
Aug 13, 20266-KReport of foreign private issuerView on EDGAR
Jul 2, 20266-KReport of foreign private issuerView on EDGAR
Jun 1, 20266-KReport of foreign private issuerView on EDGAR
May 26, 20266-KReport of foreign private issuerView on EDGAR
May 22, 20266-KReport of foreign private issuerView on EDGAR
May 18, 20266-KReport of foreign private issuerView on EDGAR
May 15, 20266-KReport of foreign private issuerView on EDGAR
Apr 27, 20266-KReport of foreign private issuerView on EDGAR
Mar 31, 202640-FAnnual report (Canadian issuer)View on EDGAR
Mar 13, 20266-KReport of foreign private issuerView on EDGAR
Feb 13, 20266-KReport of foreign private issuerView on EDGAR
Feb 10, 20266-KReport of foreign private issuerView on EDGAR
Jan 8, 20266-KReport of foreign private issuerView on EDGAR

Related